EPZ-035544

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEPZ-035544
Drug Alias NameEHMT1/2 inhibitor (Epizyme/Harvard Medical School/Dana-Farber Cancer Institute)EPZ-035544
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitorsEuchromatic Histone Lysine Methyltransferase 1 modulators
TargetsHistone-lysine N-methyltransferase EHMT2Euchromatic Histone Lysine Methyltransferase 1
Therapy Area/IndicationsHemoglobinopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpizyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteEpizyme IncHarvard Medical School
Active IndicationsN/A
Inactive IndicationsHemoglobinopathies

Other Information

ATC CodeN/A
Related LinksN/A